RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
DOD Biotech PCL - Stock

DOD Biotech PCL Employees 2024

DOD Biotech PCL Employees

286

Ticker

DOD.BK

ISIN

TH8569010003

In 2024, DOD Biotech PCL employed 286 people, a 0% change from the 286 number of employees in the previous year.

DOD Biotech PCL Aktienanalyse

What does DOD Biotech PCL do?

DOD Biotech PCL is a Thai biotechnology company specializing in the production of pharmaceuticals, diagnostics, and research products. Established in 2004, the company has become one of the most reputable biotechnology companies in Thailand. Its business model is based on the development and manufacturing of products used in medicine, veterinary medicine, and research. DOD Biotech PLC focuses on continually evolving and adapting its products to meet customer needs. Its main areas of focus are the production of pharmaceuticals, particularly anti-cancer drugs, diabetes medications, cardiovascular medications, and infection treatments. Additionally, the company manufactures diagnostics for disease early detection and precise diagnosis. It also offers a variety of products for research purposes. DOD Biotech PCL has partnerships with several companies in other countries, particularly in Asia and Europe. Its largest partner is the Indian company Sun Pharma, with which it has had a successful collaboration for many years. The company is known for its high-quality standards and is certified to ISO 9001:2015 and follows the Good Manufacturing Practices (GMP) required by the Thai FDA. DOD Biotech PCL has received international recognition, including the Frost & Sullivan Thailand Excellence Award and being recognized as a top 30 company in Thailand in 2020. Over the years, the company has built a loyal customer base that appreciates its high-quality products and excellent customer service. It has a strong online presence to better reach and serve its customers. In summary, DOD Biotech PCL is a leading biotechnology company in Thailand with a wide range of pharmaceuticals, diagnostics, and research products. It has earned an excellent reputation for its high-quality standards and top-notch customer service. With its strong online presence and partnerships with other companies in Asia and Europe, DOD Biotech PCL will undoubtedly remain an important player in the global healthcare market in the future. DOD Biotech PCL ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining DOD Biotech PCL's Employee Base

DOD Biotech PCL's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding DOD Biotech PCL's operational capacity and future potential.

Year-to-Year Comparison

Assessing DOD Biotech PCL's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

DOD Biotech PCL's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in DOD Biotech PCL’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about DOD Biotech PCL Stock

How many employees does DOD Biotech PCL have this year?

DOD Biotech PCL has 286 undefined employees this year.

How many employees did DOD Biotech PCL have compared to the previous year?

Compared to the previous year, DOD Biotech PCL had 0% more employees.

What impact did the number of employees have on the company DOD Biotech PCL?

The number of employees has a direct impact on the efficiency and productivity of DOD Biotech PCL. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of DOD Biotech PCL?

The number of employees can also have an impact on investors of DOD Biotech PCL, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of DOD Biotech PCL affect the company?

An increase in equity of DOD Biotech PCL can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in DOD Biotech PCL's equity affect the company?

A reduction in equity of DOD Biotech PCL can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of DOD Biotech PCL?

Some factors that can influence the equity of DOD Biotech PCL include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of DOD Biotech PCL so important for investors?

The equity of DOD Biotech PCL is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at DOD Biotech PCL influence the company?

The number of employees at DOD Biotech PCL can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at DOD Biotech PCL evolved in recent years?

In recent years, the number of employees at DOD Biotech PCL has changed by 0.

How many employees does DOD Biotech PCL currently have?

DOD Biotech PCL currently has 286 undefined employees.

Why is the number of employees important for investors of DOD Biotech PCL?

The number of employees is important for investors of DOD Biotech PCL as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can DOD Biotech PCL take to change the number of employees?

To change the number of employees, DOD Biotech PCL can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does DOD Biotech PCL pay?

Over the past 12 months, DOD Biotech PCL paid a dividend of 0.05 THB . This corresponds to a dividend yield of about 2.58 %. For the coming 12 months, DOD Biotech PCL is expected to pay a dividend of 0 THB.

What is the dividend yield of DOD Biotech PCL?

The current dividend yield of DOD Biotech PCL is 2.58 %.

When does DOD Biotech PCL pay dividends?

DOD Biotech PCL pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of DOD Biotech PCL?

DOD Biotech PCL paid dividends every year for the past 0 years.

What is the dividend of DOD Biotech PCL?

For the upcoming 12 months, dividends amounting to 0 THB are expected. This corresponds to a dividend yield of 0 %.

In which sector is DOD Biotech PCL located?

DOD Biotech PCL is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von DOD Biotech PCL kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DOD Biotech PCL from 5/20/2020 amounting to 0.05 THB, you needed to have the stock in your portfolio before the ex-date on 3/13/2020.

When did DOD Biotech PCL pay the last dividend?

The last dividend was paid out on 5/20/2020.

What was the dividend of DOD Biotech PCL in the year 2023?

In the year 2023, DOD Biotech PCL distributed 0 THB as dividends.

In which currency does DOD Biotech PCL pay out the dividend?

The dividends of DOD Biotech PCL are distributed in THB.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von DOD Biotech PCL

Our stock analysis for DOD Biotech PCL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DOD Biotech PCL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.